Abstract
Chronic pelvic pain (CPP) is a common pain syndrome in women worldwide, which can be difficult to manage by individual providers. CPP can result in significant debilitation and suffering for patients. A focused, systematic approach to the history and physical exam ensures that the patient’s clinical history is collected in an organized and thorough fashion. The differential diagnosis for CPP is extensive, and the causes of chronic pelvic pain are often complex and multifactorial. A systems-based approach to the differential diagnosis, guided by the patient’s clinical presentation, ensures that the provider does not miss a potential diagnosis. Treatment of CPP should target the most likely contributing causes. A trusting and caring primary care provider-patient relationship, a patient-centered approach, and the coordination of care with a team of specialists offer the best chance for successful treatment. These components are critical to ensure that all aspects of the patients’ symptoms are appropriately addressed and that treatment choices are complementary across disciplines. Patients should be counseled to understand that eradication of pain symptoms is unlikely to be a realistic outcome, but improvement in baseline pain level and quality of life are achievable with appropriate management.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mathias SD, Kuppermann M, Liberman RF, Lipschutz RC, Steege JF. Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet Gynecol. 1996;87(3):321–7.
Latthe P, Latthe M, Say L, Gulmezoglu M, Khan KS. WHO systematic review of prevalence of chronic pelvic pain: a neglected reproductive health morbidity. BMC Public Health. 2006;6:177.
Ahangari A. Prevalence of chronic pelvic pain among women: an updated review. Pain Physician. 2014;17:E141–7.
Williams RE, Hartmann KE, Steege JF. Documenting the current definitions of chronic pelvic pain: implication for research. Obstet Gynecol. 2004 Apr;103(4):686–91.
ACOG practice bulletin No. 51. Chronic pelvic pain. Obstet Gynecol. 2004;103(3):589–605.
Origoni M, Leone Roberti Maggiore U, Salvatore S, Candiani M. Neurobiological mechanisms of pelvic pain. Biomed Res Int. 2014;2014:9038484.
Brünahl C, Dybowski C, Albrecht R, Riegel B, Höink J, Fisch M, Löwe B. Mental disorders in patients with chronic pelvic pain syndrome (CPPS). J Psychosom Res. 2017;98:19–26.
Shoja MM, Sharma A, Mirzayan N, et al. Neuroanatomy of the female abdominopelvic region: a review with application to pelvic pain syndromes. Clin Anatom. 2013;26:66–76.
Cervero F, Laird M. Visceral pain. Lancet. 1999;353(9170):2145–8.
Jobling P, O'Hara K, Hua S. Female reproductive tract pain: targets, challenges, and outcomes. Front Pharmacol. 2014;5:17. Published online 2014 Feb 13. https://doi.org/10.3389/fphar.2014.00017.
Mui J, Allaire C, Williams C, Yong PJ. Abdominal wall pain in women with chronic pelvic pain. J Obstet Gynaecol Can. 2016;38(2):154–9.
Costanza CD, Longstreth GF, Liu AL. Chronic abdominal wall pain: clinical features, health care costs, and long-term outcome. Clin Gastroenterol Hepatol. 2004;2(5):395–9.
Hartmann D, Sarton J. Chronic pelvic floor dysfunction. Best Pract Res Clin Obstet Gynaecol. 2014;28(7):977–90.
Prather H, Dugan S, Fitzgerald C, Hunt D. Review of anatomy, evaluation, and treatment of musculoskeletal pelvic floor pain in women. PM R. 2009;1(4):346–58.
Apte G, Nelson P, Brismée JM, Dedrick G, Justiz R, Sizer PS. Chronic female pelvic pain- part 1: clinical pathoanatomy and examination of the pelvic region. Pain Pract. 2011;12(2):88–110.
Faubion SS, Shuster LT, Bharucha AE. Recognition and management of nonrelaxing pelvic floor dysfunction. Mayo Clin Proc. 2012;87(2):187–93. https://doi.org/10.1016/j.mayocp.2011.09.004.
Meleine M, Matricon J. Gender-related differences in irritable bowel syndrome: potential mechanisms of sex hormones. World J Gastroenterol. 2014;20(22):6725–43.
Drossman DA, Hasler WL. Rome IV-functional GI disorders: disorders of gut-brain interaction. Gastroenterology. 2016;150:1257–61.
Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(7):712–721.e4.
Forootan M, Bagheri N, Darvishi M. Chronic constipation: a review of literature. Medicine. 2018;97(20):e10631.
Wald A. Constipation: advances in diagnosis and treatment. JAMA. 2016;315:185–91.
Dahlhamer JM, Zammitti EP, Ward BW, Wheaton AG, Croft JB. Prevalence of inflammatory bowel disease among adults aged≥ 18 years—United States, 2015. MMWR Morb Mortal Wkly Rep. 2016;65:1166–9.
Feuerstein JD, Cheifetz AS. Crohn disease: epidemiology, diagnosis, and management. Mayo Clin Proc. 2017;92(7):1088–103.
Clemens JQ, Meenan RT, Rosetti MC, Gao SY, Calhoun EA. Prevalence and incidence of interstitial cystitis in a managed care population. J Urol. 2005;173:98–102.
Geerlings SE. Clinical presentations and epidemiology of urinary tract infections. Microbiol Spectrum. 2016;4(5):UTI-0002-2012. https://doi.org/10.1128/microbiolspec.UTI-0002-2012.
Borg-Stein J, Iaccarino MA. Myofascial pain syndrome treatments. Phys Med Rehabil Clin N Am. 2014;25:357–74.
Berghmans B. Physiotherapy for pelvic pain and female sexual dysfunction: an untapped resource. Int Urogynecol J. 2018;29(5):631–8.
Bonder JH, Chi M, Rispoli L. Myofascial pelvic pain and related disorders. Phys Med Rehabil Clin N Am. 2017;28:501–15.
American Psychiatric Association. DSM-5 task force. In: Diagnostic and statistical manual of mental disorders: DSM-5. 5th ed. Washington DC: American Psychiatric Association; 2013.
Lahaie MA, Boyer SC, Amsel R, Khalife S, Binik YM. Vaginismus: a review of the literature on the classification/diagnosis, etiology and treatment. Womens Health (Long). 2010 Sep;6(5):705–19.
Practice Committee of American Society for Reproductive Medicine in collaboration with Society of Reproductive Surgeons. Pathogenesis, consequences, and control of peritoneal adhesions in gynecologic surgery: a committee opinion. Fertil Steril. 2013;99(6):1550–5.
Diamond MP, El-Mowafi DM. Pelvic adhesions. Surg Technol Int. 1998;VII:273–83.
ten Broek RP, Issa Y, van Santbrink EJ, et al. Burden of adhesions in abdominal and pelvic surgery: systematic review and met-analysis. BMJ. 2013;347:f5588.
Kligman I, Drachenberg C, Papadimitriou J, Katz E. Immunohistochemical demonstration of nerve fibers in pelvic adhesions. Obstet Gynecol. 1993;82:566–8.
Cheong Y, Saran M, Hounslow JW, Reading IC. Are pelvic adhesions associated with pain, physical, emotional, and functional characteristics of women presenting with chronic pelvic pain? A cluster analysis. BMC Womens Health. 2018;18(1):11.
Powell AM, Nyirjesy P. Recurrent vulvovaginitis. Best Pract Res Clin Obstet Gynaecol. 2014;28(7):967–76.
Haefner H. Report of the ISSVD terminology and classification of vulvodynia. J Low Genit Tract Dis. 2007;11:48–9.
Kliethermes CJ, Shah M, Hoffstetter S, Gavard JA, Steele A. Effect of vestibulectomy for intractable vulvodynia. J Minim Invasive Gynecol. 2016;23(7):1152–7.
Tommola P, Unkila-Kallio L, Paavonen J. Long-term well-being after surgical or conservative treatment of severe vulvar vestibulitis. Acta Obstet Gynecol Scand. 2012;91:1086–93.
Walker E, Katon W, Harrop-Griffiths, Holm L, Russo J, Hickok LR. Relationship of chronic pelvic pain to psychiatric diagnoses and childhood sexual abuse. Am J Psychiatry. 1988;145(1):75–80.
McCauley J, Kern DE, Kolodner K, et al. Clinical characteristics of women with a history of childhood abuse: unhealed wounds. JAMA. 1997;277(17):1362–8.
Meltzer-Brody S, Leserman J, Zolnoun D, Steege J, Green E, Teich A. Trauma and posttraumatic stress disorder in women with chronic pelvic pain. Obstet Gynecol. 2007;109(4):902–8.
Meltzer-Brody S, Leserman J. Psychiatric comorbidity in women with chronic pelvic pain. CNS Spectr. 2011;16(2):29–35.
Finer LB, Zolna MR. Unintended pregnancy in the United States: incidence and disparities, 2006. Contraception. 2011;84(5):478–85.
Juhan V. Chronic pelvic pain: an imaging approach. Diagn Interv Imaging. 2015;96(10):997–1007.
Moore J, Copley S, Morris J, Lindsell D, Golding S, Kennedy S. A systematic review of the accuracy of ultrasound in the diagnosis of endometriosis. Ultrasound Obstet Gynecol. 2002;20:630–4.
Khatri G, Khan A, Rval G, Chhabra A. Diagnostic evaluation of chronic pelvic pain. Phys Med Rehabil Clin N Am. 2017;28:477–500.
Howard FM. The role of laparoscopy as a diagnostic tool in chronic pelvic pain. Baillieres Best Pract Res Clin Obstet Gynaecol. 2000;14(3):467–94.
Allaire C, Williams C, Bodmer-Roy S, Ahy S, Arion K, Ambacher K, et al. Chronic pelvic pain in an interdisciplinary setting: 1-year prospective cohort. Am J Obstet Gynecol. 2018;218:114.e1–12.
Cheong Y. Chronic pelvic pain: aetiology and therapy. Best Pract Res Clin Obstet Gynaecol. 2006;20(5):695–711.
Steege JF, Siedhoff MT. Chronic pelvic pain. Obstet Gynecol. 2014;124(3):616–29.
Black CJ, Ford AC. Chronic idiopathic constipation in adults: epidemiology, pathophysiology, diagnosis, and clinical management. Med J Aust. 2018;209(2):86–91.
Cheong YC, Smotra G, Williams ACDC. Non-surgical interventions for themanagement of chronic pelvic pain. Cochrane Database of Systematic Reviews 2014;(3). Art. No.: CD008797. https://doi.org/10.1002/14651858.CD008797.pub2.
Crisp CC, Vaccaro CM, Estanol MV, Oakley SH, Kleeman SD, Fellner AN, Pauls RN. Intra-vaginal diazepam for high-tone pelvic floor dysfunction: a randomized placebo-controlled trial. Int Urogynecol J. 2013;24(11):1915–23.
Nelson P, Apte G, Justiz R III, Brismeé JM, Dedrick G, Sizer PS. Chronic female pelvic pain-part 2: differential diagnosis and management. Pain Pract. 2012;12(2):111–41.
Bedaiwy MA, Patterson B, Mahajan S. Prevalence of myofascial chronic pelvic pain and the effectiveness of pelvic floor physical therapy. J Reprod Med. 2013;58(11–12):504–10.
Barley J, Han E, Gupta P, Gaines N, Killinger KA, Boura JA, et al. Transvaginal trigger point injections improve pain scores in women with pelvic floor hypertonicity and pelvic pain conditions. Female Pelvic Med Reconstr Surg. 2018;25:392. [Epub ahead of print].
Ay S, Evcik D, Tur BS. Comparison of injection methods in myofascial pain syndrome: a randomized controlled trial. Clin Rheumatol. 2010;29(1):19–23.
Venancio Rde A, Alencar FG, Zamperini C. Different substances and dry needling injections in patients with myofascial pain and headaches. Cranio. 2008;26(2):96–103.
Cummings TM, White AR. Needling therapies in the management of myofascial trigger point pain: a systematic review. Arch Phys Med Rehabil. 2001;82(7):986–92.
Fugl-Meyer KS, Bohm-Starke N, Damsted Petersen C, Fugl-Meyer A, Parish S, Giraldi A. Standard operating procedures for female genital sexual pain. J Sex Med. 2013;10(1):83–93.
Brotto LA, Bitzer J, Laan E, Leiblum S, Luria M. Women’s sexual desire and arousal disorders. J Sex Med. 2010;7(1 Pt 2):586–614.
Brotto LA, Basson R. Group mindfulness-based therapy significantly improves sexual desire in women. Behav Res Ther. 2014;57:43–54.
Brotto LA, Erskine Y, Carey M, et al. A brief mindfulness-based cognitive behavioral intervention improves sexual functioning versus waitlist control in women treated for gynecologic cancer. Gynecol Oncol. 2012;125(2):320–5.
Brotto LA, Basson R, Carlson M, Zhu C. Impact of an integrated mindfulness and cognitive behavioral treatment for provoked vestibulodynia (IMPROVED): a qualitative study. Sex Relatsh Ther. 2013;28(1–2):1–16.
Glazer HI, Rodke G, Swencionis C, Hertz R, Young AW. Treatment of vulvar vestibulitis syndrome with electromyographic biofeedback of pelvic floor musculature. J Reprod Med. 1995;40(4):283–90.
Bergeron S, Binik YM, Khalife S, et al. A randomized comparison group cognitive-behavioral therapy, surface electromyographic biofeedback, and vestibulectomy in the treatment of dyspareunia resulting from vulvar vestibulitis. Pain. 2001;91(3):297–306.
Goldstein AT, Pukall CF, Brown C, Bergeron S, Stein A, Kellogg-Spadt S. Vulvodynia: assessment and treatment. J Sex Med. 2016;13(4):572–90.
Danielsson L, Torstensson T, Brodda-Jansen G, Bohm-Starke N. EMG biofeedback versus topical lidocaine gel: a randomized study for the treatment of women with vulvar vestibulitis. Acta Obstet Gynecol Scand. 2006;85(11):1360–7.
Goetsch MF, Lim JY, Caughey AB. A practical solution for dyspareunia in breast cancer survivors: a randomized controlled trial. J Clin Oncol. 2015;33(30):3394–400.
Reed BD, Haefner HK, Cantor L. Vulvar dysesthesia (vulvodynia). A follow-up study. J Reprod Med. 2003;48(6):409–16.
Leo RJ. A systematic review of the utility of anticonvulsant pharmacotherapy in the treatment of vulvodynia pain. J Sex Med. 2013;10(8):2000–8.
Goldstein AT, Klingman D, Christopher K, Johnson C, Marinoff SC. Surgical treatment of vulvar vestibulitis syndrome: outcome assessment derived from a postoperative questionnaire. J Sex Med. 2006;3(5):923–31.
Bergeron S, Bouchard C, Fortier M, Binik YM, Khalife S. The surgical treatment of vulvar vestibulitis syndrome: a follow up study. J Sex Marital Ther. 1997;23(4):147–52.
Kehoe S, Luesley D. Vulvar vestibulitis treated by modified vestibulectomy. Int J Gynaecol Obstet. 1999;64(2):147–52.
Ferreira JR, Souza RP. Botulinum toxin for vaginismus treatment. Pharmacology. 2012;89(5–6):256–9.
Van den Beukel BA, de Ree R, van Leuven S, Bakkum EA, Strik C, van Goor H, Ten Broek RPG. Surgical treatment of adhesion-related chronic abdominal and pelvic pain after gynaecological and general surgery: a systematic review and meta-analysis. Hum Reprod Update. 2017;23(3):276–88.
Vrijland WW, Jeekel J, Van Geldorp HJ, Swank DJ. Abdominal adhesions: intestinal obstruction, pain and infertility. A review. Surg Endosc Ultrasound Intervent Techniques. 2003;17:1017–22.
Swank DJ, Van Erp WFM, Repelaer van Driel OJ, et al. A prospective analysis of predictive factors on the results of laparoscopic adhesiolysis in patients with chronic abdominal pain. Surg Laparosc Endosc. 2003;13:88–94.
ACOG Committee Opinion No. 673. Persistent vulvar pain. Obstet Gynecol. 2016;128:e78–84.
Sadownik LA. Etiology, diagnosis, and clinical management of vulvodynia. Int J Women's Health. 2014;6:437–49.
Bergeron S, Khalifé S, Glazer HI, Binik YM. Surgical and behavioral treatments for vestibulodynia: two-and-one-half year follow-up and predictors of outcome. Obstet Gynecol. 2008;111(1):159–66.
Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ. Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev. 2012;12:CD008242.
Jackson JL, Shimeall W, Sessums L, Dezee KJ, Becher D, Diemer M, et al. Tricyclic antidepressants and headaches: systematic review and meta-analysis. BMJ. 2010;341:c5222.
Chou R, Deyo R, Friedly J, Skelly A, Weimer M, Fu R, et al. Systemic pharmacologic therapies for low back pain: a systematic review for an American College of Physicians Clinical Practice Guideline. Ann Intern Med. 2017;166(7):480–92.
Smith RV, Havens JR, Walsh SL. Gabapentin misuse, abuse and diversion: a systematic review. Addiction. 2016;111(7):1160–74.
ACOG practice bulletin no 72: vaginitis. (2006, May). Obstet Gynecol. 2006;107:1195–206.
Vandermeer FQ, Wong-You-Cheong JJ. Imaging of acute pelvic pain. Clin Obstet Gynecol. 2009;52(1):2–20.
ACOG practice bulletin no 114: Management of Endometriosis (July 2010). Obstet Gynecol. 2010;116:223–36.
Jeong YY, Outwater EK, Kang HK. Imaging evaluation of ovarian masses. Radiographics. 2000;20:1445–70.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Review Questions
Review Questions
-
1.
A 30-year-old woman comes to your office reporting pelvic pain and vulvar irritation for the last 10 years that has been worsening over the last several weeks. She researched her symptoms online and took an over-the-counter antifungal for a presumed yeast infection. She is married and denies new sexual partners. She does report a long-standing history of burning pain with intercourse. There are no lesions on her external genitalia and bimanual exam is unremarkable. She reports severe pain from 4 o’clock to 7 o’clock along the posterior fourchette on cotton swab testing. Wet mount with 10% KOH of the vaginal discharge shows no evidence of candidal vaginitis. What is the first-line treatment of vulvodynia?
-
A.
Nonsteroidal anti-inflammatory drugs
-
B.
Vulvar care measures: wearing cotton underwear and avoiding vulvar irritants
-
C.
Vestibulectomy
-
D.
Topical lidocaine cream
-
E.
Tricyclic antidepressants
The correct answer is B. Vulvodynia is a chronic pain disorder that is defined as burning vulvar pain in the absence of relevant visible findings or a specific clinically identifiable neurological disorder. This is a diagnosis of exclusion, and treatable causes of vulvar pain, such as candidal vaginitis, must be ruled out. Other chronic skin conditions, such as lichen sclerosus, lichen planus, and vulvovaginal atrophy, should be first ruled out by careful visual examination of the vulva and perineum. Vulvar lesions may warrant biopsy in order to obtain a tissue diagnosis. Cotton swab testing along the perineum allows for mapping of the location and severity of the patient’s vulvodynia symptoms. First-line treatment for suspected vulvodynia includes lifestyle modifications with vulvar care measures that avoid vulvar irritants. Such measures include wearing 100% cotton underwear, avoiding perfumes/dyes in detergents or soaps, avoiding douching, cleaning the vulva with water only, keeping the vulvar area dry throughout the day and applying a preservative-free emollient daily, and rinsing and gently drying the vulva after urination. If lifestyle modifications do not result in improvements, then topical local anesthetics, estrogen cream, or topical tricyclic antidepressants may provide symptomatic relief. Oral tricyclic antidepressants or anticonvulsants may be incorporated as a third-line treatment. Nonsteroidal anti-inflammatory drugs usually provide minimal relief for chronic pain associated with vulvodynia. Surgical resection of the vestibule, or vestibulectomy, should be reserved for patients who have tried and failed medical management options [80, 87].
-
A.
-
2.
A 45-year-old multiparous woman presents to your office reporting pelvic pain since the birth of her last child 7 years ago. The pain is constant and sharp and radiates to her lower back. Her past medical history is significant for chronic constipation. She has not been sexually active for multiple years due to significant dyspareunia. Pelvic exam is limited due to discomfort. She has point tenderness along her left and right levator ani muscles. Which of the following is the most appropriate next step in the management of this patient?
-
A.
Recommend strict pelvic rest.
-
B.
Initiation of oral muscle relaxants.
-
C.
Initiation of low-dose long-acting narcotics.
-
D.
Referral to pelvic floor physical therapy.
The correct answer is D. Pelvic floor muscle dysfunction or myofascial pain can often be diagnosed with history and physical exam. Often, the patient will report a history of painful intercourse, painful urination, and/or pain with defecation. Pelvic floor muscle dysfunction may result from either increased muscle tone (muscle spasms) or decreased muscle tone (myofascial laxity). The most commonly affected muscles are the levator ani, obturator, and piriformis muscles which are found deep within the pelvic floor. Patients with pelvic floor dysfunction may require an interdisciplinary team including a pelvic floor physical therapist, urogynecologist, primary care physician, and psychologist. The most important first step in the management of patients with suspected pelvic floor muscle dysfunction is referral of the patient to a certified pelvic floor physical therapist for confirmation of the diagnosis and treatment. Directed therapeutic exercise or myofascial release is recommended over strict pelvic rest, which may actually worsen the pelvic floor dysfunction. Oral muscle relaxants do not specifically target the pelvic floor muscles and are often associated with increased sedation; therefore, their use should be limited. Narcotics in general are unlikely to be effective in treating pelvic floor muscle dysfunction and may worsen the patient’s chronic constipation. Patients with pelvic floor muscle spasms, who are refractory to physical therapy, may benefit from pelvic floor injections [27, 28, 55, 56].
-
A.
-
3.
A 34-year-old multiparous woman presents to your office with progressively worsening lower abdominal and pelvic pain over the past year. She has a medical history significant for fibromyalgia and irritable bowel syndrome. She states that although she experiences the pain daily, her symptoms are worst during her menses and with intercourse. She also reports a history of heavy menstrual bleeding that has been increasing in severity over the past year. On pelvic exam, her uterus is normal size/shape and non-tender. However, she has tenderness in the posterior cul-de-sac and you appreciate tender fullness along the right adnexal region. Her pregnancy test is negative. What imaging study should be ordered first to evaluate her chronic pelvic pain?
-
A.
Transvaginal ultrasound
-
B.
Computed tomography of the abdomen and pelvis
-
C.
Magnetic resonance imaging of the pelvis
-
D.
Abdominal x-ray
The correct answer is A. This patient’s symptoms of dysmenorrhea and acute worsening of her chronic pelvic pain with cul-de-sac tenderness and adnexal fullness is concerning for endometriosis. The gold standard for diagnosis of endometriosis is histologic confirmation with tissue biopsy. Radiographic evaluation for pelvic pain should identify structural causes for patient’s pain while minimizing unnecessary exposure to ionizing radiation. Transvaginal ultrasound is the optimal initial imaging modality for the evaluation of female pelvic pain because ultrasonography can delineate structural abnormalities within the uterus and adnexae without exposing the patient to radiation. Specifically, ultrasound can distinguish the characteristics of adnexal cysts as simple, complex, hemorrhagic, or endometrioma or exhibits features concerning for malignancy. Additionally, transvaginal ultrasound can be used to detect deep infiltrating endometriosis along the rectovaginal septum. Computed tomography (CT) rarely adds useful additional information to a pelvic ultrasound and exposes the patient to ionizing radiation and significantly increases cost. CT may be useful for further evaluation of patients with an adnexal mass with features concerning for malignancy. Magnetic resonance imaging (MRI) may provide better imaging of deep tissue structures; however, it is significantly more expensive than transvaginal ultrasound and unlikely to be an ideal first imaging study. None of the reproductive organs can be visualized with abdominal x-ray [88,89,90].
-
A.
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Ramirez, C.I., Tilstra, S.A., Donnellan, N.M. (2020). Chronic Pelvic Pain. In: Tilstra, S.A., Kwolek, D., Mitchell, J.L., Dolan, B.M., Carson, M.P. (eds) Sex- and Gender-Based Women's Health. Springer, Cham. https://doi.org/10.1007/978-3-030-50695-7_31
Download citation
DOI: https://doi.org/10.1007/978-3-030-50695-7_31
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-50694-0
Online ISBN: 978-3-030-50695-7
eBook Packages: MedicineMedicine (R0)